Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Jacobsen22,10.1038/s41598-022-22552-y,Pseudovirus (VSV),41598_2022_22552_MOESM2_ESM.xlsx,None,AZD1222 + mRNA-1273,2,2-6m,Human,Wild Type (B.1),=,61.9,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,17.7,1.0,=,3.5